While this study provides novel insights on incretin pathophysiology by including the entire spectrum of the natural history of type to diabetes (from normal glucose tolerance to newly diagnosed T2D), undergoing a deep metabolic evaluation of incretin secretion patters and β cell function, some limitations must be considered. The gene discussed is GCG; the disease is type 2 diabetes mellitus.